A GLOBAL SERVICE PROVIDER OF PRECLINICAL AND CLINICAL RESEARCH IN OPHTHALMOLOGY
Home » Focus in ophthalmology » Drug development process
Ocular drug development
With 24 years of experience in ophthalmology, Iris Pharma is an internationally renowned Contract Research Organization (CRO) with unique experience and knowledge of all the stages involved in developing eye medication including preclinical formulation and research in vivo (proof-of concept, GLP studies, animal research models), Phase I to IV clinical studies, medico-marketing surveys, bioanalytical testing service and strategic consulting.
For more details on a specific service in the drug development process, please click on the graph.
